Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Age is not just a number-synopsis of the 5th New Zealand Influenza Symposium 2019.

Nowlan M, Murfitt D, Turner N.

N Z Med J. 2019 Dec 13;132(1507):77-82.

PMID:
31830020
2.

One hundred years ago in 1919: New Zealand's birth reduction shock associated with an influenza pandemic.

Wilson N, Turner N, Baker MG.

N Z Med J. 2019 Dec 13;132(1507):57-62.

PMID:
31830017
3.

What Is the Evidence to Support a Correlate of Protection for Measles? A Systematic Review.

Bolotin S, Hughes SL, Gul N, Khan S, Rota PA, Severini A, Hahné S, Tricco A, Moss WJ, Orenstein W, Turner N, Durrheim D, Heffernan JM, Crowcroft N.

J Infect Dis. 2019 Nov 1. pii: jiz380. doi: 10.1093/infdis/jiz380. [Epub ahead of print]

PMID:
31674648
4.

A measles epidemic in New Zealand: Why did this occur and how can we prevent it occurring again?

Turner N.

N Z Med J. 2019 Oct 25;132(1504):8-12. No abstract available.

PMID:
31647790
5.

A Retrospective Cohort Study of Safety Outcomes in New Zealand Infants Exposed to Tdap Vaccine in Utero.

Petousis-Harris H, Jiang Y, Yu L, Watson D, Walls T, Turner N, Howe AS, Griffin JB.

Vaccines (Basel). 2019 Oct 11;7(4). pii: E147. doi: 10.3390/vaccines7040147.

6.

Influences and policies that affect immunisation coverage-a summary review of literature.

Nowlan M, Willing E, Turner N.

N Z Med J. 2019 Aug 30;132(1501):79-88. Review.

PMID:
31465331
7.

An evolution in thinking to support the post 2020 global vaccine strategy: The application of complexity and implementation science.

Dowell AC, Menning L, MacDonald N, Turner N.

Vaccine. 2019 Jul 18;37(31):4236-4240. doi: 10.1016/j.vaccine.2019.05.096. Epub 2019 Jun 22. No abstract available.

PMID:
31235372
8.

Vaccine-Preventable Disease-Associated Hospitalisations Among Migrant and Non-migrant Children in New Zealand.

Charania NA, Paynter J, Lee AC, Watson DG, Turner NM.

J Immigr Minor Health. 2020 Apr;22(2):223-231. doi: 10.1007/s10903-019-00888-4.

PMID:
30945094
10.

Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.

Thompson MG, Pierse N, Sue Huang Q, Prasad N, Duque J, Claire Newbern E, Baker MG, Turner N, McArthur C; SHIVERS investigation team.

Vaccine. 2018 Sep 18;36(39):5916-5925. doi: 10.1016/j.vaccine.2018.07.028. Epub 2018 Aug 1.

PMID:
30077480
11.

Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006-2015.

Petousis-Harris H, Howe AS, Paynter J, Turner N, Griffin J.

Clin Infect Dis. 2019 Feb 15;68(5):818-826. doi: 10.1093/cid/ciy570.

PMID:
30032236
12.

Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine.

Griffin JB, Yu L, Watson D, Turner N, Walls T, Howe AS, Jiang Y, Petousis-Harris H.

Vaccine. 2018 Aug 16;36(34):5173-5179. doi: 10.1016/j.vaccine.2018.07.011. Epub 2018 Jul 18.

PMID:
30031662
13.

Exploring immunisation inequities among migrant and refugee children in New Zealand.

Charania NA, Paynter J, Lee AC, Watson DG, Turner NM.

Hum Vaccin Immunother. 2018;14(12):3026-3033. doi: 10.1080/21645515.2018.1496769. Epub 2018 Aug 17.

14.

Risk Factors and Attack Rates of Seasonal Influenza Infection: Results of the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) Seroepidemiologic Cohort Study.

Huang QS, Bandaranayake D, Wood T, Newbern EC, Seeds R, Ralston J, Waite B, Bissielo A, Prasad N, Todd A, Jelley L, Gunn W, McNicholas A, Metz T, Lawrence S, Collis E, Retter A, Wong SS, Webby R, Bocacao J, Haubrock J, Mackereth G, Turner N, McArdle B, Cameron J, Reynolds EG, Baker MG, Grant CC, McArthur C, Roberts S, Trenholme A, Wong C, Taylor S, Thomas P, Duque J, Gross D, Thompson MG, Widdowson MA; Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) Investigation Team.

J Infect Dis. 2019 Jan 9;219(3):347-357. doi: 10.1093/infdis/jiy443.

PMID:
30016464
15.

Quantifying the incidence and burden of herpes zoster in New Zealand general practice: a retrospective cohort study using a natural language processing software inference algorithm.

Turner NM, MacRae J, Nowlan ML, McBain L, Stubbe MH, Dowell A.

BMJ Open. 2018 May 31;8(5):e021241. doi: 10.1136/bmjopen-2017-021241.

16.

Identifying factors behind the general practice use of the term 'decline' for the childhood immunisation programme in New Zealand.

Turner N, Taylor L, Chong A, Horrell B.

J Prim Health Care. 2017 Mar;9(1):69-77. doi: 10.1071/HC16031.

PMID:
29530190
17.

Outreach immunisation services in NewZealand: a review of service delivery models.

Roberts L, Turner N, McArdle B, Nowlan M, Taylor L, Webber R, Rouse P.

J Prim Health Care. 2017 Mar;9(1):62-68. doi: 10.1071/HC16012.

PMID:
29530189
18.

RETRACTED: Association of prior HPV vaccination with reduced preterm birth: A population based study.

Lawton B, Howe AS, Turner N, Filoche S, Slatter T, Devenish C, Hung NA.

Vaccine. 2018 Jan 2;36(1):134-140. doi: 10.1016/j.vaccine.2017.11.020. Epub 2017 Nov 27.

PMID:
29174108
19.

Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study.

Wong SS, Oshansky CM, Guo XJ, Ralston J, Wood T, Seeds R, Newbern C, Waite B, Reynolds G, Widdowson MA, Huang QS, Webby RJ, Thomas PG; SHIVERS Investigation Team.

J Infect Dis. 2018 Jan 4;217(2):245-256. doi: 10.1093/infdis/jix571.

PMID:
29112724
20.

Supplemental Content

Loading ...
Support Center